ISBI 2020 Patrons & Supporters
The conference organizers gratefully acknowledge the generous support provided by the following
At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey toward expanding precision medicine, transforming care delivery, and improving patient experience, all made possible by digitalizing healthcare.
An estimated 5 million patients globally benefit every day from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics, and molecular medicine, as well as digital health and enterprise services.
We are a leading medical technology company with over 120 years of experience and 18,000 patents globally. Through the dedication of more than 50,000 colleagues in 75 countries, we will continue to innovate and shape the future of healthcare.
Canon Medical ResearchPatron
Canon Medical Research USA, Inc. (CMRU) and Canon Medical Research Europe (CMRE) are R&D centers for Canon Medical Systems, a leading company in medical imaging, which offers a full range of diagnostic imaging solutions including CT, MR, X-Ray, Ultrasound and Healthcare Informatics across the globe.
Canon Medical Research USA, Inc. (CMRU) is a multi-modality R&D center that designs the next generation medical imaging systems. Headquartered in Chicago, with offices in Cleveland, and San Francisco, CMRU is the center of excellence for system development, imaging algorithms and embedded software, etc. Throughout the years, we have delivered many new features to flagship products across modalities offered by Canon Medical System. Our mission is to drive healthcare solutions that result in a higher quality of life in an atmosphere that values all people and ideas. Together we work for a healthier future.
Canon Medical Research Europe is a leading medical software research and development center of excellence, generating breakthrough technologies and valuable intellectual property for Canon Medical Systems. Based in the diverse city of Edinburgh we employ over 130 people working as Software Engineers, Scientists, Clinical Specialists, Testers and Business Support and are part of a global corporation headquartered in Japan. We develop next generation medical imaging software, technology components and AI solutions that integrate with Canon Medical scanners and diagnostic healthcare systems which are installed in hospitals and healthcare centers across the globe.
IDx is a leading AI diagnostics company on a mission to transform the quality, accessibility, and affordability of healthcare. Founded in 2010 by a team of world-renowned clinician scientists, the company is focused on developing clinically-aligned autonomous AI that detect disease in medical images. By enabling diagnostic assessment in primary care settings, IDx aims to increase patient access to high-quality, affordable disease detection.
The company’s first product, IDx-DR, is an FDA-cleared autonomous AI-based diagnostic system designed for use at the front lines of care to detect diabetic retinopathy. IDx is developing additional AI-based diagnostic systems for the detection of macular degeneration, glaucoma, Alzheimer’s disease, cardiovascular disease, and stroke risk.
United Imaging IntelligencePatron
Shanghai United Imaging Intelligence (UII) is the medical AI company within the United Imaging Group. UII was founded on December 21, 2017 in Shanghai, China. UII offers full-stack, full-spectrum AI solutions throughout the entire clinical workflow, spanning imaging, screening, follow-up, diagnosis, therapy, and treatment. Together with partners and users, with state-of-the-art AI algorithms, UII products and solutions empower medical imaging devices, clinical workflow, and scientific research.
The headquarter of the company is located in Shanghai, China, with branch offices in Beijing, Wuhan, Chengdu, Shenzhen, Xi’an, and Boston, USA.
uAI - Make AI a best friend for our customers.
VIDA is transforming pulmonary care through intelligence. Powered by a unique combination of AI and quality-controlled image analysis services, VIDA’s solution aims to provide greater precision and personalization across a range of lung diseases including cancer, emphysema, airway obstructive diseases, asthma and interstitial lung disease. LungPrint® is part of the VIDA|vision® Software Suite and available for clinical use in the USA, EU, Canada and Australia. More at vidalung.ai.
The mission of the Iowa Institute for Biomedical Imaging (IIBI) is to foster efficient and cooperative inter-disciplinary and cross-college research and discovery in biomedical imaging, and to improve training and education within the broader community at the University of Iowa.